Home › Compare › GMRE vs JNJ

GMRE vs JNJ: Dividend Comparison 2026

GMRE yields 9.23% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GMRE wins by $1.3K in total portfolio value
10 years
GMRE
GMRE
● Live price
9.23%
Share price
$35.74
Annual div
$3.30
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.3K
Annual income
$0.98
Full GMRE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GMRE vs JNJ

📍 GMRE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGMREJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GMRE + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GMRE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GMRE
Annual income on $10K today (after 15% tax)
$784.83/yr
After 10yr DRIP, annual income (after tax)
$0.83/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $702.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GMRE + JNJ for your $10,000?

GMRE: 50%JNJ: 50%
100% JNJ50/50100% GMRE
Portfolio after 10yr
$20.7K
Annual income
$414.38/yr
Blended yield
2.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GMRE
Analyst Ratings
13
Buy
9
Hold
Consensus: Buy
Price Target
$40.00
+11.9% upside vs current
Range: $40.00 — $40.00
Altman Z
0.2
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GMRE buys
0
JNJ buys
0
No recent congressional trades found for GMRE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGMREJNJ
Forward yield9.23% ✓3.36%
Annual dividend / share$3.30$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR-50%5.8% ✓
Portfolio after 10y$21.3K ✓$20.0K
Annual income after 10y$0.98$827.78 ✓
Total dividends collected$949.00 ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$40.00$228.73 ✓

Year-by-year: GMRE vs JNJ ($10,000, DRIP)

YearGMRE PortfolioGMRE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,162$461.67$10,676$355.77+$486.00 → GMRE
2$12,184$240.79$11,407$389.39+$777.00 → GMRE
3$13,159$122.82$12,198$426.53+$961.00 → GMRE
4$14,143$61.99$13,056$467.62+$1.1K → GMRE
5$15,164$31.13$13,987$513.12+$1.2K → GMRE
6$16,241$15.60$14,998$563.56+$1.2K → GMRE
7$17,385$7.81$16,098$619.52+$1.3K → GMRE
8$18,606$3.90$17,295$681.69+$1.3K → GMRE
9$19,911$1.95$18,599$750.82+$1.3K → GMRE
10$21,305$0.98$20,022$827.78+$1.3K → GMRE

GMRE vs JNJ: Complete Analysis 2026

GMRE — Stock

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Full GMRE Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GMRE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GMRE vs SCHDGMRE vs JEPIGMRE vs OGMRE vs KOGMRE vs MAINGMRE vs ABBVGMRE vs MRKGMRE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.